CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 13.50
+0.50 (3.85%)
Apr 29, 2026, 11:44 AM GMT
CRISM Therapeutics Revenue
CRISM Therapeutics had revenue of 25.00K GBP in the twelve months ending June 30, 2025, down -44.44% year-over-year. In the year 2024, CRISM Therapeutics had annual revenue of 25.00K, down -44.44%.
Revenue
25.00K
Revenue Growth
-44.44%
P/S Ratio
269.02
Revenue / Employee
6.25K
Employees
4
Market Cap
6.73M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OptiBiotix Health | 1.15M |
| Futura Medical | 7.93M |
| Thalia Therapeutics | 7.07K |
| Oxford BioDynamics | 1.10M |
| IXICO | 6.53M |
| BSF Enterprise | 52.84K |
| Fusion Antibodies | 1.60M |
CRISM Therapeutics News
- 8 months ago - AIM Market Roundup: Renalytix, Sunrise Resources, Crism Therapeutics - The Armchair Trader
- 10 months ago - AIM Market Roundup: Mobile Tornado, Mediazest, Pri0r1ty Intelligence - The Armchair Trader
- 1 year ago - AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy - The Armchair Trader